Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Throughput Surface-Enhanced Raman Spectroscopy Platform for Multiplex Detection of Uremic Metabolites Relevant to Chronic Kidney Disease.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Human Serum Albumin Affinity for Putrescine Using ITC and STD-NMR.

International journal of molecular sciences·2025
Same author

Binding Capacity and Adsorption Stability of Uremic Metabolites to Albumin-Modified Magnetic Nanoparticles.

International journal of molecular sciences·2025
Same author

Transparent Janus Nanofibers for Use in Blood-Contact Applications.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Effect of End-Tethered Methoxy-PEO Chain Density on Uremic Toxin Adsorption.

ACS applied bio materials·2024
Same author

Effect of Uremic Toxins and Methoxy-PEO Chain Density on Plasma Protein Adsorption.

ACS biomaterials science & engineering·2024

Related Experiment Video

Updated: Jun 27, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

10.3K

Hemocompatibility of Albumin-Modified Magnetic Nanoparticles.

Indu Sharma1, Mehdi Gaffari Sharaf1, Aishwarya Pawar1

  • 1Department of Chemical and Material Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.

International Journal of Molecular Sciences
|November 27, 2024
PubMed
Summary

Iron oxide magnetic nanoparticles show promise for clearing uremic toxins. Albumin modification reduces protein adsorption and clotting, improving hemocompatibility for kidney failure patients.

Keywords:
adsorptionalbuminclot kineticshemodialysismagnetic nanoparticles

More Related Videos

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.6K

Related Experiment Videos

Last Updated: Jun 27, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
11:28

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

10.3K
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.6K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Nephrology

Background:

  • Kidney failure causes metabolite accumulation (uremic toxins), increasing patient mortality and morbidity.
  • Uremic toxins bind to serum albumin, hindering clearance by standard hemodialysis.
  • Adsorbents, particularly iron oxide magnetic nanoparticles, offer a next-generation solution for toxin removal.

Purpose of the Study:

  • To evaluate the hemocompatibility of unmodified and albumin-modified iron oxide magnetic nanoparticles.
  • To assess the impact of surface modification on plasma protein adsorption and clot formation kinetics.

Main Methods:

  • Fabrication and characterization of albumin-coated iron oxide magnetic nanoparticles using TEM, TGA, and zeta-potential analysis.
  • Analysis of clotting kinetics, total protein adsorption, and specific protein levels via immunoblots.

Main Results:

  • Albumin-modified nanoparticles exhibited significantly reduced protein adsorption and slower clotting compared to unmodified nanoparticles.
  • Immunoblot analysis revealed altered levels of key proteins (albumin, protein C, IgG, fibrinogen, etc.) on modified surfaces.
  • Surface modification with albumin enhances hemocompatibility for potential clinical use.

Conclusions:

  • Albumin modification of iron oxide magnetic nanoparticles improves their hemocompatibility by reducing protein adsorption and clotting.
  • These modified nanoparticles represent a promising advancement for developing effective adsorbents to clear uremic toxins in kidney failure patients.